Dr. Reddy’s drug prices in crosshairs of two states

Eric Palmer

Generic Dr. Reddy's Laboratories, which already has had to defend its pricing to a couple of members of Congress, is now being called to account by the attorneys general of both Texas and California.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS